The Town College of New York is pausing its investigation into a college member, an Alzheimer’s researcher accused of misconduct, the college mentioned in a commentary on Friday.

Research via the neuroscientist, Hoau-Yan Wang, underpin an Alzheimer’s drug in complicated medical trials. The drug, simufilam, is made via Cassava Sciences, a pharmaceutical corporate primarily based in Texas. Dr. Wang regularly collaborated with Lindsay H. Burns, the corporate’s leader scientist.

“As a result of questions in regards to the confidentiality and integrity of this investigation were raised, CUNY will keep the underlying inquiry into the allegations relating to Dr. Wang’s analysis till such time because the College completes a complete investigation of the method,” the college mentioned.

Dr. Wang didn’t reply to a request for remark.

“Since September 2021, Cassava Sciences has been looking forward to a competent and credible investigation from CUNY,” Remi Barbier, Cassava’s founder and leader government, mentioned in an electronic mail. “We’re nonetheless ready.”

From the beginning, some scientists had been skeptical of simufilam’s purported mode of motion and later of Cassava’s experiences of enhancements amongst its medical trial contributors. Following accusations in 2021 that Dr. Wang and Cassava can have manipulated knowledge, the Securities and Alternate Fee and the Nationwide Institutes of Well being started investigating the analysis.

A committee convened via CUNY additionally started an investigation into Dr. Wang’s paintings and his lab’s budget over 20 years.

On Oct. 12, the magazine Science made public a draft of the committee’s file, which concluded that Dr. Wang used to be “reckless” in his failure to stay or supply authentic knowledge, an offense that “quantities to important analysis misconduct.” (The investigators additionally concluded that Dr. Burns used to be accountable for mistakes in one of the vital papers.)

CUNY declined to remark at the report on the time however mentioned it might officially liberate the file this month. Since then, critics have wondered the objectivity of the investigators and the veracity in their descriptions of Dr. Wang’s responses to the inquiry.

On Friday, the college declined to touch upon those allegations past its authentic commentary.

“In line with its coverage, CUNY won’t remark at the accuracy of the investigation referenced within the articles as a result of no ultimate motion as to this investigation has been taken,” the commentary mentioned.

“CUNY is dedicated to making sure that its investigative processes are held to the best procedural and moral requirements and that the equity of the lawsuits is preserved for all events,” the college added. “To that finish, any discovering relating to allegations of study misconduct will have to be dependable and credible.”